Wester; Ronald T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wester; Ronald T..The latest application filed is for "tyk2 inhibitors and uses thereof".

Company Profile

4.26.19

Wester; Ronald T. - Ledyard CT
Wester; Ronald T. - Mystic CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
TYK2 inhibitors and uses thereof Grant 11,434,240 - Masse , et al. September 6, 2	2022-09-06
Tyk2 Inhibitors And Uses Thereof App 20210238198 - Dahlgren; Markus ; et al.	2021-08-05
TYK2 inhibitors and uses thereof Grant 10,968,236 - Dahlgren , et al. April 6, 2	2021-04-06
Tyk2 Inhibitors And Uses Thereof App 20210047319 - MASSE; Craig E. ; et al.	2021-02-18
TYK2 inhibitors and uses thereof Grant 10,781,204 - Masse , et al. Sept	2020-09-22
Tyk2 Inhibitors And Uses Thereof App 20190248810 - Dahlgren; Markus ; et al.	2019-08-15
TYK2 inhibitors and uses thereof Grant 10,253,046 - Dahlgren , et al.	2019-04-09
TYK2 inhibitors and uses thereof Grant 10,196,390 - Masse , et al. Fe	2019-02-05
Tyk2 Inhibitors And Uses Thereof App 20180354949 - Masse; Craig E. ; et al.	2018-12-13
TYK2 inhibitors and uses thereof Grant 10,023,571 - Masse , et al. July 17, 2	2018-07-17
Tyk2 Inhibitors And Uses Thereof App 20170305933 - Dahlgren; Markus ; et al.	2017-10-26
IRAK inhibitors and uses thereof Grant 9,751,892 - Greenwood , et al. September 5, 2	2017-09-05
Tyk2 Inhibitors And Uses Thereof App 20170247373 - Masse; Craig E. ; et al.	2017-08-31
TYK2 inhibitors and uses thereof Grant 9,630,970 - Masse , et al. April 25, 2	2017-04-25
Tyk2 Inhibitors And Uses Thereof App 20170066763 - Masse; Craig E. ; et al.	2017-03-09
Tyk2 Inhibitors And Uses Thereof App 20160297826 - Masse; Craig E. ; et al.	2016-10-13
Tyk2 Inhibitors And Uses Thereof App 20160251376 - Dahlgren; Markus ; et al.	2016-09-01
Irak Inhibitors And Uses Thereof App 20160193216 - Harriman; Geraldine C. ; et al.	2016-07-07
TYK2 inhibitors and uses thereof Grant 9,340,540 - Masse , et al. May 17, 2	2016-05-17
Irak Inhibitors And Uses Thereof App 20160068543 - Greenwood; Jeremy Robert ; et al.	2016-03-10
Irak Inhibitors And Uses Thereof App 20160002256 - Harriman; Geraldine C. ; et al.	2016-01-07
IRAK inhibitors and uses thereof Grant 9,212,190 - Harriman , et al. December 15, 2	2015-12-15
IRAK inhibitors and uses thereof Grant 9,175,007 - Greenwood , et al. November 3, 2	2015-11-03
Tyk2 Inhibitors And Uses Thereof App 20150266875 - MASSE; Craig E. ; et al.	2015-09-24
IRAK inhibitors and uses thereof Grant 9,067,948 - Harriman , et al. June 30, 2	2015-06-30
Irak Inhibitors And Uses Thereof App 20140194417 - Greenwood; Jeremy Robert ; et al.	2014-07-10
Irak Inhibitors And Uses Thereof App 20140018357 - Harriman; Geraldine C. ; et al.	2014-01-16
Irak Inhibitors And Uses Thereof App 20130231328 - Harriman; Geraldine C. ; et al.	2013-09-05
N-[(substituted five-membered di-or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia Grant 6,974,813 - Hamanaka , et al. December 13, 2	2005-12-13
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines App 20050245570 - DeNinno, Michael P. ; et al.	2005-11-03
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,906,082 - DeNinno , et al. June 14, 2	2005-06-14
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines App 20040092550 - DeNinno, Michael P. ; et al.	2004-05-13
N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia App 20030149043 - Hamanaka, Ernest S. ; et al.	2003-08-07
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,586,448 - DeNinno , et al. July 1, 2	2003-07-01
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,489,478 - DeNinno , et al. December 3, 2	2002-12-03
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,395,751 - DeNinno , et al. May 28, 2	2002-05-28
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,362,198 - Goldstein , et al. March 26, 2	2002-03-26
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,310,075 - DeNinno , et al. October 30, 2	2001-10-30
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,197,786 - DeNinno , et al. March 6, 2	2001-03-06
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,147,090 - DeNinno , et al. November 14, 2	2000-11-14
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines Grant 6,147,089 - DeNinno , et al. November 14, 2	2000-11-14
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines Grant 6,140,342 - Goldstein , et al. October 31, 2	2000-10-31
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines Grant 6,140,343 - DeNinno , et al. October 31, 2	2000-10-31
Angiotensin II receptor antagonists Grant 5,338,740 - Carpino , et al. August 16, 1	1994-08-16
Nor-statine and nor-cyclostatine polypeptides Grant 4,814,342 - Hoover , et al. March 21, 1	1989-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.